Enzymotec Files Annual Report on Form 20-F for the Year Ended December 31, 2015

Enzymotec Ltd. (NASDAQ:ENZY) (“Company”), a developer, manufacturer and marketer of innovative bio-active lipid-based nutritional ingredients and medical foods, announced today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2015 with the U.S. Securities and Exchange Commission (“SEC”). The annual report on Form 20-F, which contains audited financial statements, can be accessed on the SEC’s website at http://www.sec.gov/ as well as via the Company’s investor relations website at http://ir.enzymotec.com/.

The Company will also deliver a hard copy of its annual report on Form 20-F, including its complete audited financial statements, free of charge, to its shareholders upon request to Oren Bryan at [e-mail].

About Enzymotec Ltd.Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures, and markets innovative bio-active lipid based nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies intended to improve people’s health.  For more information, visit www.enzymotec.com.

Company Contact:
Enzymotec Ltd.
Oren Bryan
Chief Financial Officer
Phone: [phone]
[e-mail]

Investor Relations Contact:
The Ruth Group
Tram Bui / Lee Roth
Phone: [phone] / 7012
[e-mail]
[e-mail]